Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Labor/HHS

This article was originally published in The Tan Sheet

Executive Summary

Office of Dietary Supplements urged to "continue and expand" research initiative on ephedra safety and efficacy under Senate appropriations bill passed Oct. 11. ODS, NCCAM have commissioned an AHRQ study on ephedra, which could be released as early as August 2002 (1"The Tan Sheet" Aug. 13, p. 10). Appropriations bill also urges ODS to "allocate sufficient funds to expand the number of botanical research centers," with hypericum, echinacea suggested subjects of study. Bill would allocate NCCAM $110 mil. for FY 2002 (2"The Tan Sheet" Oct. 15, In Brief)

You may also be interested in...



ODS Methods, Reference Materials Program To Be Directed By AHPA’s Betz

Joseph Betz, PhD, is joining NIH's Office of Dietary Supplements to oversee a new program to facilitate development and validation of analytical methods and reference materials for dietary supplements

ODS Methods, Reference Materials Program To Be Directed By AHPA’s Betz

Joseph Betz, PhD, is joining NIH's Office of Dietary Supplements to oversee a new program to facilitate development and validation of analytical methods and reference materials for dietary supplements

ODS Methods, Reference Materials Program To Be Directed By AHPA’s Betz

Joseph Betz, PhD, is joining NIH's Office of Dietary Supplements to oversee a new program to facilitate development and validation of analytical methods and reference materials for dietary supplements

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS093175

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel